100% Quality Guarantee
PhD-Level Technical Support
Human Cell Biology ELISA Kits 2 Human CAPN2 / Calpain 2 ELISA Kit
Key Features

Human CAPN2/Calpain 2 ELISA Kit (HUFI01843)

SKU HUFI01843
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 0.094 ng/mL
Range 0.156-10 ng/mL
$857

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human CAPN2/Calpain 2 ELISA Kit

The Human CAPN2 (Calpain-2) ELISA Kit is specifically designed for the precise measurement of calpain-2 levels in human serum, plasma, and cell culture supernatants. This kit offers exceptional sensitivity and specificity, ensuring consistent and accurate results for various research applications. Calpain-2, a member of the calpain family of calcium-dependent proteases, plays a crucial role in various cellular processes, including cell migration, adhesion, and apoptosis. Dysregulation of calpain-2 has been implicated in several diseases, such as muscular dystrophy, neurodegenerative disorders, and cancer, highlighting its importance as a potential biomarker for disease diagnosis and therapeutic development.

With its reliable performance and ease of use, the Human CAPN2 ELISA Kit is an invaluable tool for researchers studying the role of calpain-2 in health and disease, providing valuable insights into the mechanisms underlying these conditions and enabling the development of novel treatment strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose